
Here: the most notable changes in the new AAN guideline on mild cognitive impairment.
Here: the most notable changes in the new AAN guideline on mild cognitive impairment.
A study looked at changes in retinal signs with fundus photography and their association with cognitive decline.
5 key facts about the association between cerebral microbleeds and risk of future intracerebral hemorrhage in patients with afib who take oral anticoagulants after ischemic stroke.
A large retrospective cohort study of over 12,000 patients from 40 hospitals looked at the risk of death following stroke or TIA, and whether patients had been prescribed antihypertensive medications.
A large study evaluated exercise and its effects on cognitive function in patients with, or at risk for, Alzheimer disease.
Lower serum caffeine levels may be of diagnostic significance in early Parkinson disease, consistent with epidemiologic data that support the neuro-protective properties of caffeine.
In this 6-minute video presentation, Dr. Andrew Wilner describes the epidemiology and pathophysiology of carbon monoxide poisoning and reviews the implications of a recently published observational study.
Although rare, new onset refractory status epilepticus can be life threatening if not identified quickly.
Findings from a study lends credence to the role of lipids in the early stages of Alzheimer disease.
An incident, population-based prospective cohort study examined weight changes over time in patients with Parkinson disease.
Researchers conducted a retrospective analysis of patients with acute stroke and evaluated the effect of infection during the hospitalization period.
A study that compared motor and nonmotor outcomes of DBS for Parkinson disease may show promise for patients' quality of life.
A study of over 80,000 patients confirmed another strong reason to prevent young people from repetitive head blows.
Marijuana has been employed since ancient times for the treatment of epilepsy. However, rigorous scientific data supporting its efficacy has been essentially nonexistent until recently.
In this video, Dr. Lazzara discusses a new study that identified patients at greatest risk of memory loss and global loss of cognitive function.
A new study makes the case for alternatives to opioids in the treatment of migraine.
Causes of concussion include direct trauma, rapid acceleration-deceleration, and blast injury. Dr. Wilner discusses recent literature.
A meta-analysis compared medical therapy with medical therapy plus angioplasty for the treatment of symptomatic vertebral artery stenosis.
Patients underwent one night of a sham stimulation followed by pink noise stimulation delivered during slow wave activity.
An abstract presented at ACC 2017 explored the cardiovascular effects of cannabis use.
Peter Goadsby, MD discusses the efficacy, safety, & tolerability of the CGRP inhibitor erenumab in a phase III trial of participants with episodic migraine.
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
Did testosterone treatment improve cognitive function and memory in elderly men diagnosed with low testosterone and age-related memory impairment?
Is selective serotonin reuptake inhibitor use associated with an increased risk of spontaneous intracranial hemorrhage?
Is the parkinsonian phenotype seen in welders related to the exposure of manganese-containing welding fumes?
What factors contributed to burnout among your fellow neurologists, and what can you do to reduce your own risk?
Although sauna bathing can be beneficial in cardiovascular disease, how does the practice impact dementia and Alzheimer disease?
Could marijuana use increase the risk of developing Alzheimer disease?
Research in a mouse model identified a source of stem cells in the meninges.